SMART Health Cards: Vaccination & Testing Implementation Guide
0.6.2 - STU 1 (Ballot Version) International flag

SMART Health Cards: Vaccination & Testing Implementation Guide, published by HL7 International - Public Health Work Group. This is not an authorized publication; it is the continuous build for version 0.6.2). This version is based on the current content of https://github.com/HL7/fhir-shc-vaccination-ig/ and changes regularly. See the Directory of published versions

ValueSet: Vaccine: ATC/DDD

Official URL: http://hl7.org/fhir/uv/shc-vaccination/ValueSet/vaccine-atc Version: 0.6.2
Active as of 2022-06-27 Computable Name: VaccineATC

Copyright/Legal: This artifact includes content from Anatomical Therapeutic Chemical (ATC) classification system. ATC codes are copyright World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. Terms & Conditions in https://www.whocc.no/use_of_atc_ddd/

This value set includes the subset of ATC that identify vaccine targets.

Note that an ATC code for COVID-19 vaccines (J07BX03) has been created and will be added to the next published version of ATC/DDD slated for January 2022.

References

Logical Definition (CLD)

 

Expansion

This value set contains 117 concepts

Expansion based on http://www.whocc.no/atc version 2020-05

All codes in this table are from the system http://www.whocc.no/atc

CodeDisplay
  J07VACCINES
  J07ABACTERIAL VACCINES
  J07ACAnthrax vaccines
  J07AC01anthrax antigen
  J07ADBrucellosis vaccines
  J07AD01brucella antigen
  J07AECholera vaccines
  J07AE01cholera, inactivated, whole cell
  J07AE02cholera, live attenuated
  J07AE51cholera, combinations with typhoid vaccine, inactivated, whole cell
  J07AFDiphtheria vaccines
  J07AF01diphtheria toxoid
  J07AGHaemophilus influenzae B vaccines
  J07AG01haemophilus influenzae B, purified antigen conjugated
  J07AG51haemophilus influenzae B, combinations with toxoids
  J07AG52haemophilus influenzae B, combinations with pertussis and toxoids
  J07AG53haemophilus influenzae B, combinations with meningococcus C, conjugated
  J07AHMeningococcal vaccines
  J07AH01meningococcus A, purified polysaccharides antigen
  J07AH02other meningococcal monovalent purified polysaccharides antigen
  J07AH03meningococcus A,C, bivalent purified polysaccharides antigen
  J07AH04meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen
  J07AH05other meningococcal polyvalent purified polysaccharides antigen
  J07AH06meningococcus B, outer membrane vesicle vaccine
  J07AH07meningococcus C, purified polysaccharides antigen conjugated
  J07AH08meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
  J07AH09meningococcus B, multicomponent vaccine
  J07AH10meningococcus A, purified polysaccharides antigen conjugated
  J07AJPertussis vaccines
  J07AJ01pertussis, inactivated, whole cell
  J07AJ02pertussis, purified antigen
  J07AJ51pertussis, inactivated, whole cell, combinations with toxoids
  J07AJ52pertussis, purified antigen, combinations with toxoids
  J07AKPlague vaccines
  J07AK01plague, inactivated, whole cell
  J07ALPneumococcal vaccines
  J07AL01pneumococcus, purified polysaccharides antigen
  J07AL02pneumococcus, purified polysaccharides antigen conjugated
  J07AL52pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated
  J07AMTetanus vaccines
  J07AM01tetanus toxoid
  J07AM51tetanus toxoid, combinations with diphtheria toxoid
  J07AM52tetanus toxoid, combinations with tetanus immunoglobulin
  J07ANTuberculosis vaccines
  J07AN01tuberculosis, live attenuated
  J07APTyphoid vaccines
  J07AP01typhoid, oral, live attenuated
  J07AP02typhoid, inactivated, whole cell
  J07AP03typhoid, purified polysaccharide antigen
  J07AP10typhoid, combinations with paratyphi types
  J07ARTyphus (exanthematicus) vaccines
  J07AR01typhus exanthematicus, inactivated, whole cell
  J07AXOther bacterial vaccines
  J07BVIRAL VACCINES
  J07BAEncephalitis vaccines
  J07BA01encephalitis, tick borne, inactivated, whole virus
  J07BA02encephalitis, Japanese, inactivated, whole virus
  J07BA03encephalitis, Japanese, live attenuated
  J07BBInfluenza vaccines
  J07BB01influenza, inactivated, whole virus
  J07BB02influenza, inactivated, split virus or surface antigen
  J07BB03influenza, live attenuated
  J07BB04influenza, virus like particles
  J07BCHepatitis vaccines
  J07BC01hepatitis B, purified antigen
  J07BC02hepatitis A, inactivated, whole virus
  J07BC20combinations
  J07BDMeasles vaccines
  J07BD01measles, live attenuated
  J07BD51measles, combinations with mumps, live attenuated
  J07BD52measles, combinations with mumps and rubella, live attenuated
  J07BD53measles, combinations with rubella, live attenuated
  J07BD54measles, combinations with mumps, rubella and varicella, live attenuated
  J07BEMumps vaccines
  J07BE01mumps, live attenuated
  J07BFPoliomyelitis vaccines
  J07BF01poliomyelitis oral, monovalent, live attenuated
  J07BF02poliomyelitis oral, trivalent, live attenuated
  J07BF03poliomyelitis, trivalent, inactivated, whole virus
  J07BF04poliomyelitis oral, bivalent, live attenuated
  J07BGRabies vaccines
  J07BG01rabies, inactivated, whole virus
  J07BHRota virus diarrhea vaccines
  J07BH01rota virus, live attenuated
  J07BH02rota virus, pentavalent, live, reassorted
  J07BJRubella vaccines
  J07BJ01rubella, live attenuated
  J07BJ51rubella, combinations with mumps, live attenuated
  J07BKVaricella zoster vaccines
  J07BK01varicella, live attenuated
  J07BK02zoster, live attenuated
  J07BK03zoster, purified antigen
  J07BLYellow fever vaccines
  J07BL01yellow fever, live attenuated
  J07BMPapillomavirus vaccines
  J07BM01papillomavirus (human types 6, 11, 16, 18)
  J07BM02papillomavirus (human types 16, 18)
  J07BM03papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  J07BXOther viral vaccines
  J07BX01smallpox vaccines
  J07BX02ebola vaccines
  J07CBACTERIAL AND VIRAL VACCINES, COMBINED
  J07CABacterial and viral vaccines, combined
  J07CA01diphtheria-poliomyelitis-tetanus
  J07CA02diphtheria-pertussis-poliomyelitis-tetanus
  J07CA03diphtheria-rubella-tetanus
  J07CA04haemophilus influenzae B and poliomyelitis
  J07CA05diphtheria-hepatitis B-pertussis-tetanus
  J07CA06diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
  J07CA07diphtheria-hepatitis B-tetanus
  J07CA08haemophilus influenzae B and hepatitis B
  J07CA09diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
  J07CA10typhoid-hepatitis A
  J07CA11diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B
  J07CA12diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
  J07CA13diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C
  J07XOTHER VACCINES

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code